Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure. New treatment options

A Galbraith1, G Wright-Smith

  • 1Lung and Heart Transplant Unit, The Prince Charles Hospital, Chermside, Queensland.

Australian Family Physician
|July 1, 1996
PubMed
Summary

Effective heart failure treatment starts with angiotensin converting inhibitors, with doses escalated quickly. Additional therapies like diuretics, digoxin, vasodilators, or beta-blockers are added as needed for optimal patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling Intermittent Running from a Single-visit Field Test.

International journal of sports medicine·2015
Same author

An integrated approach to management of Marfan syndrome caused by an FBN1 exon 18 mutation in an Australian Aboriginal family.

Clinical genetics·2004
Same author

Primary oxalosis with cardiac involvement: echocardiographic features of an unusual form of cardiomyopathy.

Circulation·2001
Same author

IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation.

Blood·2001
Same author

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

Proceedings of the National Academy of Sciences of the United States of America·1999
Same author

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.

Journal of the American College of Cardiology·1999

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Heart failure management remains suboptimal, with delays in disseminating treatment guidelines to general practitioners.
  • Current treatment protocols for heart failure require optimization for improved patient outcomes.

Purpose of the Study:

  • To outline current evidence-based treatment strategies for heart failure.
  • To emphasize the importance of timely and appropriate pharmacological interventions in heart failure management.

Main Methods:

  • Review of current literature and clinical guidelines on heart failure pharmacotherapy.
  • Discussion of stepwise treatment approaches based on patient response and symptom severity.

Main Results:

  • Angiotensin converting inhibitors are recommended as first-line therapy, with rapid dose titration.
  • Diuretics and digoxin are indicated for fluid overload (oedema).
  • Vasodilators and beta-blockers may be added for refractory symptoms or specific indications.

Conclusions:

  • Early initiation and aggressive titration of angiotensin converting inhibitors are crucial for heart failure management.
  • A sequential addition of other medications, including diuretics, digoxin, vasodilators, and beta-blockers, is essential for achieving therapeutic goals.
  • Comprehensive management may involve considering antiarrhythmics, anticoagulants, and surgical options in select patients.

Related Experiment Videos